Showing 391-400 of 1560 results for "".
Epilepsy Essentials: The Current and Future Landscape of Tuberous Sclerosis Complex Diagnosis and Treatment
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-the-current-and-future-landscape-of-tuberous-sclerosis-complex-diagnosis-and-treatment/32157/Prenatal diagnosis, genetic testing, and mTOR inhibitors have fundamentally transformed the treatment of tuberous sclerosis complex in the neurology clinic.Coming & Going: September/October 2022
https://modernaesthetics.com/topics/energy-based-devices/coming-going-septemberoctober-2022/35215/Analyzing the Clinical Evidence
https://modernaesthetics.com/topics/sponsored-articles/analyzing-the-clinical-evidence/49015/Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC
https://reachmd.com/programs/cme/rethinking-the-therapeutic-targeting-of-b7-h3-in-es-sclc/37876/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
https://reachmd.com/programs/cme/clinical-criteria-and-imaging-strategies-for-b7-h3directed-adcs-in-es-sclc/39977/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
https://reachmd.com/programs/cme/emerging-clinical-evidence-for-b7-h3directed-adcs-in-es-sclc-from-wclc-2025/37877/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC
https://reachmd.com/programs/cme/translating-clinical-data-into-multidisciplinary-practice-for-es-sclc/37878/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.Clinical Implications of Emerging Data on B7-H3–directed ADCs in the Future of ES-SCLC
https://reachmd.com/programs/cme/clinical-implications-of-emerging-data-on-b7-h3directed-adcs-in-the-future-of-es-sclc/39979/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From ESMO 2025
https://reachmd.com/programs/cme/emerging-clinical-evidence-for-b7-h3directed-adcs-in-es-sclc-from-esmo-2025/39978/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.Transformative Insights: Latest Evidence for B7-H3 ADCs From WCLC and ESMO 2025
https://reachmd.com/programs/cme/transformative-insights-latest-evidence-for-b7-h3-adcs-from-wclc-and-esmo-2025/36238/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.